Antibody induced by predicted B-cell multi-epitope protein can neutralize and recognize three different strains of ALV-J.
A variant antigenic neutralizing epitope was identified using reverse vaccinology methods.
The founder epitope and its variants can react with all anti-ALV-J sera from field, indicating the potential value for the novel multi-epitope vaccine development.